RxDoctor Payments DataLook up a doctor →

Naga Lakshmana Nidadavolu, MD

Neuromuscular Medicine · Saint Cloud, FLNPI 1386835601

Payments from drug & device makers

$8,694in general payments, 2019–2025

Across 529 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$1K
  • Bristol Myers Squibb$698
  • Novartis$457
  • UCB, Inc.$388
  • Lilly USA, LLC$357
  • plus $4K from 43 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)147$1,776
Pfizer80$1,045
Bristol Myers Squibb38$698
Novartis28$457
UCB, Inc.14$388
Lilly USA, LLC25$357
Biogen17$320
Lundbeck LLC19$318
EMD Serono, Inc.12$293
Amgen(2 entities)15$290
Teva Pharmaceuticals USA, Inc.11$248
Eisai Inc.9$197
Supernus Pharmaceuticals, Inc.7$174
Acadia Pharmaceuticals Inc8$147
Sunovion Pharmaceuticals Inc.6$117
Neurelis, Inc.6$113
Argenx US, Inc.6$105
Sanofi5$103
Axsome Therapeutics, Inc.4$100
Genentech USA, Inc.4$99
Tanabe Pharma America, Inc.4$97
Johnson & Johnson5$93
Boston Scientific4$92
Livanova USA, Inc.5$83
SK Life Science, Inc.3$75
Alnylam Pharmaceuticals Inc.3$73
Avion Pharmaceuticals4$72
MDD US Operations, LLC4$72
Grifols USA, LLC4$70
Neurocrine Biosciences, Inc.3$69
TG Therapeutics, Inc.2$62
Aucta Pharmaceuticals, Inc.6$58
Xeris Pharmaceuticals, Inc.2$41
Amneal Pharmaceuticals LLC3$41
Cala Health, Inc.1$41
Vanda Pharmaceuticals Inc.2$34
Microtransponder, Inc.1$30
Merz Pharmaceuticals, LLC1$27
Ceribell, Inc.1$25
Hyperfine Operations, Inc.1$23
Avanir Pharmaceuticals, Inc.1$22
Otsuka America Pharmaceutical, Inc.1$20
Biotronik NRO, Inc.1$20
CSL Behring1$20
Abbott1$19
Cycle Pharmaceuticals Inc1$19
AstraZeneca1$18
Scilex Pharmaceuticals Inc.1$17
Corium, LLC1$17

How this compares

Too few neuromuscular medicine providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$834,102
Medicare patients
1,362
Services billed
5,188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuromuscular medicine in Saint Cloud

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →